These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 35803625)

  • 1. Supplemental oxygen strategies in infants with bronchopulmonary dysplasia after the neonatal intensive care unit period: study protocol for a randomised controlled trial (SOS BPD study).
    Balink S; Onland W; Vrijlandt EJLE; Andrinopoulou ER; Bos AF; Dijk PH; Goossens L; Hulsmann AR; Nuytemans DH; Reiss IKM; Sprij AJ; Kroon AA; van Kaam AH; Pijnenburg M;
    BMJ Open; 2022 Jul; 12(7):e060986. PubMed ID: 35803625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Position management on pulmonary function and bronchopulmonary dysplasia in premature infants: study protocol for a randomised controlled trial.
    Yang L; Bao Z; Zhang L; Lei X; Zhang L
    BMJ Open; 2022 Dec; 12(12):e062291. PubMed ID: 36521889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The N3RO trial: a randomised controlled trial of docosahexaenoic acid to reduce bronchopulmonary dysplasia in preterm infants < 29 weeks' gestation.
    Collins CT; Gibson RA; Makrides M; McPhee AJ; Sullivan TR; Davis PG; Thio M; Simmer K; Rajadurai VS;
    BMC Pediatr; 2016 Jun; 16():72. PubMed ID: 27250120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enteral supplementation with high-dose docosahexaenoic acid on the risk of bronchopulmonary dysplasia in very preterm infants: a collaborative study protocol for an individual participant data meta-analysis.
    Marc I; Lavoie PM; McPhee AJ; Collins CT; Simonyan D; Pronovost E; Guillot M; Gould JF; Mohamed I; Beltempo M; Boutin A; Fortier I; Sullivan TR; Moore L; Makrides M
    BMJ Open; 2023 Jul; 13(7):e076223. PubMed ID: 37518076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Providing Oxygen during Intubation in the NICU Trial (POINT): study protocol for a randomised controlled trial in the neonatal intensive care unit in the USA.
    Herrick HM; O'Reilly M; Lee S; Wildenhain P; Napolitano N; Shults J; Nishisaki A; Foglia EE
    BMJ Open; 2023 Apr; 13(4):e073400. PubMed ID: 37055198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enteral vitamin A for reducing severity of bronchopulmonary dysplasia in extremely preterm infants: a randomised controlled trial.
    Rakshasbhuvankar A; Patole S; Simmer K; Pillow JJ
    BMC Pediatr; 2017 Dec; 17(1):204. PubMed ID: 29246130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Inhaled Nitric Oxide on Survival Without Bronchopulmonary Dysplasia in Preterm Infants: A Randomized Clinical Trial.
    Hasan SU; Potenziano J; Konduri GG; Perez JA; Van Meurs KP; Walker MW; Yoder BA;
    JAMA Pediatr; 2017 Nov; 171(11):1081-1089. PubMed ID: 28973344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sound reduction management in the neonatal intensive care unit for preterm or very low birth weight infants.
    Almadhoob A; Ohlsson A
    Cochrane Database Syst Rev; 2015 Jan; 1():CD010333. PubMed ID: 25633155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhaled versus systemic corticosteroids for preventing bronchopulmonary dysplasia in ventilated very low birth weight preterm neonates.
    Shah SS; Ohlsson A; Halliday HL; Shah VS
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD002058. PubMed ID: 29041034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhaled versus systemic corticosteroids for the treatment of bronchopulmonary dysplasia in ventilated very low birth weight preterm infants.
    Shah SS; Ohlsson A; Halliday HL; Shah VS
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD002057. PubMed ID: 29035425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Revisiting the Definition of Bronchopulmonary Dysplasia: Effect of Changing Panoply of Respiratory Support for Preterm Neonates.
    Isayama T; Lee SK; Yang J; Lee D; Daspal S; Dunn M; Shah PS;
    JAMA Pediatr; 2017 Mar; 171(3):271-279. PubMed ID: 28114678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxygen saturation/FIO2 ratio at 36 weeks' PMA in 1005 preterm infants: Effect of gestational age and early respiratory disease patterns.
    Nobile S; Marchionni P; Gidiucci C; Correani A; Palazzi ML; Spagnoli C; Rondina C; ; Carnielli VP
    Pediatr Pulmonol; 2019 May; 54(5):637-643. PubMed ID: 30688034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hospital variation and risk factors for bronchopulmonary dysplasia in a population-based cohort.
    Lapcharoensap W; Gage SC; Kan P; Profit J; Shaw GM; Gould JB; Stevenson DK; O'Brodovich H; Lee HC
    JAMA Pediatr; 2015 Feb; 169(2):e143676. PubMed ID: 25642906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High doses of enteral docosahexaenoic acid omega-3 supplementation for prevention of bronchopulmonary dysplasia in very preterm infants: a protocol for a systematic review and meta-analysis.
    Marc I; Boutin A; Pronovost E; Guillot M; Bergeron F; Moore L; Makrides M
    BMJ Open; 2022 Oct; 12(10):e064515. PubMed ID: 36253040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Less invasive surfactant administration versus endotracheal surfactant instillation followed by limited peak pressure ventilation in preterm infants with respiratory distress syndrome in China: study protocol for a randomized controlled trial.
    Zhu J; Bao Y; Du L; Huang H; Lv Q; Jiang Y; Dai Y; Chen Z; Shi J; Shi Y; Yang C; Mei H; Jiang H; Sun Y; Sun X
    Trials; 2020 Jun; 21(1):516. PubMed ID: 32527290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Hydrocortisone Therapy Initiated 7 to 14 Days After Birth on Mortality or Bronchopulmonary Dysplasia Among Very Preterm Infants Receiving Mechanical Ventilation: A Randomized Clinical Trial.
    Onland W; Cools F; Kroon A; Rademaker K; Merkus MP; Dijk PH; van Straaten HL; Te Pas AB; Mohns T; Bruneel E; van Heijst AF; Kramer BW; Debeer A; Zonnenberg I; Marechal Y; Blom H; Plaskie K; Offringa M; van Kaam AH;
    JAMA; 2019 Jan; 321(4):354-363. PubMed ID: 30694322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does chronic oxygen dependency in preterm infants with bronchopulmonary dysplasia at NICU discharge predict respiratory outcomes at 3 years of age?
    Lodha A; Ediger K; Rabi Y; Lodha S; Tang S; Bhandari A; Sauve R; Bhandari V
    J Perinatol; 2015 Jul; 35(7):530-6. PubMed ID: 25719546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Steroid use for established bronchopulmonary dysplasia: study protocol for a systematic review and meta-analysis.
    Strashun S; Seliga-Siwecka J; Chioma R; Zielińska K; Włodarczyk K; Villamor E; Philip RK; Assaf NA; Pierro M
    BMJ Open; 2022 Jun; 12(6):e059553. PubMed ID: 35705335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Home Oxygen Use and 1-Year Readmission among Infants Born Preterm with Bronchopulmonary Dysplasia Discharged from Children's Hospital Neonatal Intensive Care Units.
    Lagatta J; Murthy K; Zaniletti I; Bourque S; Engle W; Rose R; Ambalavanan N; Brousseau D
    J Pediatr; 2020 May; 220():40-48.e5. PubMed ID: 32093927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Volumetric Capnography at 36 Weeks Postmenstrual Age and Bronchopulmonary Dysplasia in Very Preterm Infants.
    Neumann RP; Gerull R; Zannin E; Fouzas S; Schulzke SM
    J Pediatr; 2022 Feb; 241():97-102.e2. PubMed ID: 34687691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.